Clinical Trial Results:
Albumin administration in the prevention of hepatorenal syndrome and death in patients with cirrhosis, bacterial infections other than spontaneous bacterial peritonitis and high risk of hospital mortality.
|
Summary
|
|
EudraCT number |
2013-002416-27 |
Trial protocol |
NO ES IT BE DE AT DK IE GB NL |
Global completion date |
|
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
|
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
23 Oct 2025
|
First version publication date |
23 Oct 2025
|
Other versions |
|
Summary report(s) |
INFECIR-2 Submission note Copy of the INFECIR-2 medical journal article |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.